Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate. (Record no. 18132779)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02007 a2200505 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515130930.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200812s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1879-0852 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.ejca.2008.06.003 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Sciot, Raf |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20081210 |
245 00 - TITLE STATEMENT | |
Title | Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | European journal of cancer (Oxford, England : 1990) |
Date of publication, distribution, etc. | Sep 2008 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1855-60 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, CD34 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzamides |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Exons |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gastrointestinal Stromal Tumors |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Imatinib Mesylate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunohistochemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Piperazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins c-kit |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimidines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, Platelet-Derived Growth Factor alpha |
General subdivision | genetics |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Debiec-Rychter, Maria |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Daugaard, Soren |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fisher, Cyril |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Collin, Francoise |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Glabbeke, Martine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Verweij, Jaap |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Blay, Jean-Yves |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hogendoorn, Pancras C W |
773 0# - HOST ITEM ENTRY | |
Title | European journal of cancer (Oxford, England : 1990) |
Related parts | vol. 44 |
-- | no. 13 |
-- | p. 1855-60 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.ejca.2008.06.003">https://doi.org/10.1016/j.ejca.2008.06.003</a> |
Public note | Available from publisher's website |
No items available.